Search

Displaying results 8711 - 8720 of 9686 in total
  1. Drug

    KAND567

    go.drugbank.com/drugs/DB16511
    Investigational

    KAND567, a small molecule, blocks the fractaline (CX3CL1) receptor, which mediates the immune system response to inflammation[L32908]. … Because COVID-19 involves cytotoxic cells associated with this pathway, KAND567 is currently being tested as a treatment for those with the illness[L32908].

  2. Drug

    Zofin

    go.drugbank.com/drugs/DB16519
    Investigational

    Zofin, previously known as Organicell Flow, is a nanoparticle-based therapeutic derived from perinatal sources which is manufactured in a way that retains the naturally occurring microRNAs without the

  3. Drug

    KB109

    go.drugbank.com/drugs/DB16531
    Experimental

    KB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.

  4. Drug

    Zirconium dioxide

    go.drugbank.com/drugs/DB16552
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Vitis vinifera seed

    go.drugbank.com/drugs/DB16606
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB16646
    Approved

    Categories: Inactivated Influenza A Virus VaccineSynonyms: Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated), Haemagglutinin-strain A (H5N1)
  7. Drug

    Epcoritamab

    go.drugbank.com/drugs/DB16672
    ApprovedInvestigational

    [L46516] It is administered subcutaneously and is currently being evaluated as a monotherapy and in combination for the treatment of a variety of hematologic malignancies. … Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

  8. Drug

    Mibavademab

    go.drugbank.com/drugs/DB16673
    Investigational

    Mibavademab is under investigation in clinical trial NCT04159415 (Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy).

  9. Drug

    Nadecnemab

    go.drugbank.com/drugs/DB16677
    Investigational

    Nadecnemab is under investigation in clinical trial NCT03956550 (A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee).

  10. Drug

    Odronextamab

    go.drugbank.com/drugs/DB16684
    ApprovedInvestigational

    [L43887,L43892] A phase I clinical study (NCT02290951) showed that in heavily pre-treated patients with B-cell non-Hodgkin lymphoma, odronextamab elicited a durable response with a manageable safety … Odronextamab is a hinge-stabilized, fully human immunoglobulin G4 (IgG4)-based CD20×CD3 bispecific antibody currently evaluated for the treatment of relapsed/refractory (R/R) B-Cell non-Hodgkin lymphoma